The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Ishares Msci South Africa Index Fund

NYSE: EZA
Last

(U.S.) $57.16

Today's change-0.91 -1.57%
Updated August 28 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Ishares Msci South Africa Index Fund

NYSE: EZA
Last

(U.S.) $57.16

Today's change-0.91 -1.57%
Updated August 28 4:00 PM -4GMT. Delayed by at least 15 minutes.

Ishares Msci South Africa Index Fund down (U.S.)$0.91

Ishares Msci South Africa Index Fund closed sharply lower Friday, dropping (U.S.)$0.91 or 1.57% to (U.S.)$57.16. Over the last five days, shares have gained 2.90%, but are down 11.82% for the last year to date. Shares have underperformed the S&P 500 by 19.58% during the last year.

Key company metrics

  • Open(U.S.) $57.49
  • Previous close(U.S.) $58.07
  • High(U.S.) $57.68
  • Low(U.S.) $56.73
  • Bid / Ask-- / --
  • YTD % change-11.82%
  • Volume966,681
  • Average volume (10-day)880,275
  • Average volume (1-month)669,760
  • Average volume (3-month)517,232
  • 52-week range(U.S.) $51.94 to (U.S.) $73.08
  • Beta1.07
  • Trailing P/E13.19×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.37
  • Dividend yield2.40%
  • Trailing EPS(U.S.) $4.33
Updated August 28 4:00 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+341.32%

Based on its net profit margin of 341.32%, Ishares Msci South Africa Index Fund is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.71%Sector:FinancialsIndustry:Investment Trusts
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q4/2014Q2/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedFeb 28, 201502/28/2015Aug 31, 201408/31/2014Feb 28, 201402/28/2014Aug 31, 201308/31/2013
Revenue5887
Total other revenue--------
Total revenue5887
Gross profit4675
Total cost of revenue1222
Total operating expense1222
Selling / general / administrative--------
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income4675
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-237038-45
Income after tax-237038-45
Income tax, total--000
Net income-237038-45
Total adjustments to net income--------
Net income before extra. items-237038-45
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-237038-45
Inc. avail. to common incl. extra. items-237038-45
Diluted net income-237038-45
Dilution adjustment--------
Diluted weighted average shares79711
Diluted EPS excluding extraordinary itemsvalue per share-3.187.525.26-4.19
Dividends per sharevalue per share0.800.620.920.66
Diluted normalized EPSvalue per share-3.187.525.26-4.19